Radioactive psma doses
Ended Awarded Last action
- Contract number
- 36C25523F0001
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 15
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $720,392
Award facts
- Contract value 100% obligated
- $720,392.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$17,457 | |
| Original award | $737,850 |
About this award
This is a delivery order contract awarded by the Department of Veterans Affairs (VA) to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. and subsidiary of Lantheus Holdings, Inc. The contract, valued at $720,392.25, is for the provision of radioactive PSMA (prostate-specific membrane antigen) doses. The contract is a total small business set-aside and is issued under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB).
The contract provides for the delivery of PYLARIFY, a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect and image prostate cancer. This contract supports the VA's healthcare services and the provision of critical diagnostic imaging capabilities to federal healthcare providers, particularly in the area of oncology. Lantheus Holdings, Inc., the parent company of Progenics Pharmaceuticals, is an established federal contractor providing radiopharmaceuticals, nuclear medicine supplies, and other specialized medical imaging products to government agencies, including the VA, Defense Health Agency, and National Institutes of Health.
Quick answers
Who was awarded contract 36C25523F0001?
36C25523F0001 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 15 (Veterans Health Administration) on October 14, 2022.
How much is contract 36C25523F0001 worth?
The government has obligated $720,392 on 36C25523F0001.
Is contract 36C25523F0001 an order under another contract?
Yes. 36C25523F0001 is a delivery order under 36F79719D0170, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25523F0001 competed?
The extent of competition for 36C25523F0001 was full and open competition. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award